We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cites Sovereign Pharmaceuticals for Building Failures, Unwritten Procedures
FDA Cites Sovereign Pharmaceuticals for Building Failures, Unwritten Procedures
Sovereign Pharmaceuticals’ Texas facility received a Form 483 after an inspection in November found numerous problems in the facility, including the building’s construction.